Differences of osteoblastic bone metastases and osteolytic bone metastases in clinical features and molecular characteristics
出版年份 2014 全文链接
标题
Differences of osteoblastic bone metastases and osteolytic bone metastases in clinical features and molecular characteristics
作者
关键词
Bone metastases, Differences, Clinical features, Molecular characteristics, Bone targets
出版物
Clinical & Translational Oncology
Volume 17, Issue 3, Pages 173-179
出版商
Springer Nature
发表日期
2014-10-29
DOI
10.1007/s12094-014-1247-x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Comparative Efficacy of Bisphosphonates in Metastatic Breast and Prostate Cancer and Multiple Myeloma: A Mixed-Treatment Meta-analysis
- (2013) C. Palmieri et al. CLINICAL CANCER RESEARCH
- Phase III, Randomized, Placebo-Controlled Study of Docetaxel in Combination With Zibotentan in Patients With Metastatic Castration-Resistant Prostate Cancer
- (2013) Karim Fizazi et al. JOURNAL OF CLINICAL ONCOLOGY
- Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors
- (2013) David Henry et al. SUPPORTIVE CARE IN CANCER
- Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study
- (2012) F. Nuzzo et al. ANNALS OF ONCOLOGY
- Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to bone
- (2012) Joel B. Nelson et al. CANCER
- Bisphosphonates in the Adjuvant Treatment of Breast Cancer
- (2012) M.C. Winter et al. CLINICAL ONCOLOGY
- Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials
- (2012) Allan Lipton et al. EUROPEAN JOURNAL OF CANCER
- Complexities of TGF-β Targeted Cancer Therapy
- (2012) Erin C. Connolly et al. International Journal of Biological Sciences
- Inhibition of Breast Cancer Metastases by a Novel Inhibitor of TGFβ Receptor 1
- (2012) Yuanzhang Fang et al. JNCI-Journal of the National Cancer Institute
- Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial
- (2012) Alexander HG Paterson et al. LANCET ONCOLOGY
- Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells
- (2011) Nilay Sethi et al. CANCER CELL
- BMP4 Promotes Prostate Tumor Growth in Bone through Osteogenesis
- (2011) Y.-C. Lee et al. CANCER RESEARCH
- Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST Trial
- (2011) Antonio Llombart et al. Clinical Breast Cancer
- Dickkopf1: A tumor suppressor or metastasis promoter?
- (2011) Mitchell E. Menezes et al. INTERNATIONAL JOURNAL OF CANCER
- TGF-β Signaling in Breast Cancer Cell Invasion and Bone Metastasis
- (2011) Yvette Drabsch et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind,
- (2010) Nicholas D. James et al. BJU INTERNATIONAL
- Combined inhibition of the BMP pathway and the RANK-RANKL axis in a mixed lytic/blastic prostate cancer lesion
- (2010) Mandeep S. Virk et al. BONE
- Nuclear co-localization and functional interaction of COX-2 and HIF-1α characterize bone metastasis of human breast carcinoma
- (2010) Paola Maroni et al. BREAST CANCER RESEARCH AND TREATMENT
- Growth factors to stimulate bone formation
- (2010) David J. Baylink et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Predictors of survival in patients with prostate cancer and spinal metastasis
- (2010) Dan Michael Drzymalski et al. JOURNAL OF NEUROSURGERY-SPINE
- Targeting the Transforming Growth Factor-β pathway inhibits human basal-like breast cancer metastasis
- (2010) Vidya Ganapathy et al. Molecular Cancer
- Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases
- (2010) Nanda K. Thudi et al. PROSTATE
- Examining the Metastatic Niche: Targeting the Microenvironment
- (2010) Theresa Guise SEMINARS IN ONCOLOGY
- Bone-marker levels in patients with prostate cancer: potential correlations with outcomes
- (2010) Fred Saad et al. Current Opinion in Supportive and Palliative Care
- Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials
- (2009) David P Dearnaley et al. LANCET ONCOLOGY
- Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma
- (2008) Y.-W. Qiang et al. BLOOD
- Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid
- (2008) Allan Lipton et al. CANCER
- Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer
- (2008) Joel B. Nelson et al. CANCER
- Bone markers and their prognostic value in metastatic bone disease: Clinical evidence and future directions
- (2008) Robert Coleman et al. CANCER TREATMENT REVIEWS
- Predictors of Survival in Patients With Bone Metastasis of Lung Cancer
- (2008) Hideshi Sugiura et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Molecular mechanisms and treatment of bone metastasis
- (2008) Gregory A. Clines et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Transforming growth factor-β1 is the predominant isoform required for breast cancer cell outgrowth in bone
- (2008) A A Mourskaia et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More